CORT insider trading

Latest SEC Form 4 filings by CORT officers, directors and 10% owners.

Showing the last 30 days. 82 older filings are PRO.See full history →

Open-market buys (0)

No open-market insider buys in recent CORT filings.

WILSON JAMES N
Director
$761.7K
Open-market sale · 6,654 sh @ $114.48
Traded 2026-10-15 · Filed 2026-10-16
WILSON JAMES N
Director
$34.9K
Open-market sale · 300 sh @ $116.30
Traded 2026-10-15 · Filed 2026-10-16
WILSON JAMES N
Director
$351.5K
Open-market sale · 3,046 sh @ $115.39
Traded 2026-10-15 · Filed 2026-10-16
Vieira Roberto Wandenkolk
President, Oncology
$126.0K
Open-market sale · 1,100 sh @ $114.52
Traded 2026-10-02 · Filed 2026-10-05
Vieira Roberto Wandenkolk
President, Oncology
$600.1K
Open-market sale · 5,147 sh @ $116.58
Traded 2026-10-02 · Filed 2026-10-05
Vieira Roberto Wandenkolk
President, Oncology
$241.4K
Open-market sale · 2,086 sh @ $115.73
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$552.9K
Open-market sale · 4,744 sh @ $116.54
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$514.4K
Open-market sale · 4,446 sh @ $115.70
Traded 2026-10-02 · Filed 2026-10-05
Maduck Sean
See Remarks
$1.84M
Open-market sale · 15,843 sh @ $116.12
Traded 2026-10-02 · Filed 2026-10-05
Maduck Sean
See Remarks
$1.02M
Open-market sale · 8,744 sh @ $116.55
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$93.5K
Open-market sale · 810 sh @ $115.40
Traded 2026-10-01 · Filed 2026-10-05
Maduck Sean
See Remarks
$47.7K
Open-market sale · 413 sh @ $115.54
Traded 2026-10-01 · Filed 2026-10-05

Insider	Transaction	Shares	Price	Value	Traded	Filed
WILSON JAMES N Director	Open-market sale	6,654	$114.48	$761.7K	2026-10-15	2026-10-16
WILSON JAMES N Director	Open-market sale	300	$116.30	$34.9K	2026-10-15	2026-10-16
WILSON JAMES N Director	Open-market sale	3,046	$115.39	$351.5K	2026-10-15	2026-10-16
Vieira Roberto Wandenkolk President, Oncology	Open-market sale	1,100	$114.52	$126.0K	2026-10-02	2026-10-05
Vieira Roberto Wandenkolk President, Oncology	Open-market sale	5,147	$116.58	$600.1K	2026-10-02	2026-10-05
Vieira Roberto Wandenkolk President, Oncology	Open-market sale	2,086	$115.73	$241.4K	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Open-market sale	4,744	$116.54	$552.9K	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Open-market sale	4,446	$115.70	$514.4K	2026-10-02	2026-10-05
Maduck Sean See Remarks	Open-market sale	15,843	$116.12	$1.84M	2026-10-02	2026-10-05
Maduck Sean See Remarks	Open-market sale	8,744	$116.55	$1.02M	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Open-market sale	810	$115.40	$93.5K	2026-10-01	2026-10-05
Maduck Sean See Remarks	Open-market sale	413	$115.54	$47.7K	2026-10-01	2026-10-05

Grants, option exercises, tax withholding and gifts. These usually aren’t a view on the stock.

Vieira Roberto Wandenkolk
President, Oncology
$180.2K
Option exercise · 8,333 sh @ $21.63
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$112.3K
Option exercise · 5,833 sh @ $19.26
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$45.5K
Option exercise · 3,357 sh @ $13.56
Traded 2026-10-02 · Filed 2026-10-05
Maduck Sean
See Remarks
$203.3K
Option exercise · 24,587 sh @ $8.27
Traded 2026-10-02 · Filed 2026-10-05
Lyon Joseph Douglas
See Remarks
$11.0K
Option exercise · 810 sh @ $13.56
Traded 2026-10-01 · Filed 2026-10-05
Maduck Sean
See Remarks
$3.4K
Option exercise · 413 sh @ $8.27
Traded 2026-10-01 · Filed 2026-10-05

Insider	Transaction	Shares	Price	Value	Traded	Filed
Vieira Roberto Wandenkolk President, Oncology	Option exercise	8,333	$21.63	$180.2K	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Option exercise	5,833	$19.26	$112.3K	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Option exercise	3,357	$13.56	$45.5K	2026-10-02	2026-10-05
Maduck Sean See Remarks	Option exercise	24,587	$8.27	$203.3K	2026-10-02	2026-10-05
Lyon Joseph Douglas See Remarks	Option exercise	810	$13.56	$11.0K	2026-10-01	2026-10-05
Maduck Sean See Remarks	Option exercise	413	$8.27	$3.4K	2026-10-01	2026-10-05

Source: SEC Form 4 filings. For education and research only. Not financial advice.